menu
    • menu

    Company profile for Hinge Bio

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hinge Bio, Inc. is a privately-held biotechnology company leveraging its powerful GEM-⁠DIMER™ platform to develop therapeutics that address the problems of resistance, inadequate efficacy, and side effects in the fields of cancer, inflammatory disease and infectious disease. The GEM-DIMER™ technology uniquely enables (i) cooperative binding to disease targets allowing for orders-of-magnitude enhanced activity and (ii)...
    Hinge Bio, Inc. is a privately-held biotechnology company leveraging its powerful GEM-⁠DIMER™ platform to develop therapeutics that address the problems of resistance, inadequate efficacy, and side effects in the fields of cancer, inflammatory disease and infectious disease. The GEM-DIMER™ technology uniquely enables (i) cooperative binding to disease targets allowing for orders-of-magnitude enhanced activity and (ii) greater degrees of multivalency and multispecificity than possible with conventional approaches, to produce molecules with entirely new functionality for superior safety and efficacy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hinge BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    863 Mitten Road, Suite 100L Burlingame, CA 94010
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hingebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hinge-bio-inc/about/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hinge Bio Gets FDA Nod For HB2198, In Lupus Therapy
    Hinge Bio Gets FDA Nod For HB2198, In Lupus Therapy

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165493/0/en/Hinge-Bio-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-HB2198-a-Novel-B-cell-Depleting-Agent-for-Patients-with-Systemic-Lupus-Erythematosus-and-Lupus-Nephrit.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Kyorin Pens $105m Pact For Japan Rights To Hinge's Lupus Drug
    Kyorin Pens $105m Pact For Japan Rights To Hinge's Lupus Drug

    01 Oct 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/kyorin-pens-105m-pact-japan-rights-hinges-preclinical-lupus-drug

    FIERCE BIOTECH
    01 Oct 2025
    Share Share
    Hinge Bio Collaborates With Kyorin Pharma On Hb2198
    Hinge Bio Collaborates With Kyorin Pharma On Hb2198

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3159137/0/en/Hinge-Bio-Announces-License-and-Collaboration-with-Kyorin-Pharmaceutical-Co-Ltd-for-the-Development-and-Commercialization-of-HB2198-in-Japan-for-Autoimmune-Diseases.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Hinge Bio Expands Leadership, Publishes GEM-DIMER Data
    Hinge Bio Expands Leadership, Publishes GEM-DIMER Data

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144316/0/en/Hinge-Bio-Expands-Leadership-Team-to-Drive-Clinical-Development-of-GEM-DIMER-Programs-and-Announces-Publication-in-Scientific-Reports.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Hinge Bio Secures Major Funding For Advanced Therapy Platform
    Hinge Bio Secures Major Funding For Advanced Therapy Platform

    15 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/15/3009892/0/en/Hinge-Bio-Raises-30-Million-Series-A-Financing-to-Develop-Next-Generation-Therapies-via-its-Proprietary-GEM-DIMER-Platform.html

    GLOBENEWSWIRE
    15 Jan 2025
    Share Share
    Hinge Bio Presents GEM-DIMER™ Data at ACR Convergence 2024
    Hinge Bio Presents GEM-DIMER™ Data at ACR Convergence 2024

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2981029/0/en/Hinge-Bio-Presents-Preclinical-Data-from-its-GEM-DIMER-Programs-Targeting-B-Cell-Depletion-at-the-American-College-of-Rheumatology-ACR-Convergence-2024.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search